Metraipolis › archive › dc_a301e009dcda

Prospective Evaluation of the Cardiovascular Effects of BRAF and MEK Inhibitors in Patients With Melanoma — Europe PMC PMID:41065626

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41065626
DOI: 10.1016/j.jaccao.2025.08.006
License (as archived): solo-consultazione
Archived: 2026-11-09T10:01:56.026Z
SHA-256 of the archived text: b42017937d178c703fdb39e36b44ff82650dd71496ec9481dfc43a429ff0a90e
Stable URL of this page: https://metraipolis.com/documento/dc_a301e009dcda

How to cite

Prospective Evaluation of the Cardiovascular Effects of BRAF and MEK Inhibitors in Patients With Melanoma — Europe PMC PMID:41065626 — Europe PMC (en), https://europepmc.org/article/MED/41065626 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a301e009dcda (Metraipolis archive dc_a301e009dcda, sha256 b42017937d178c703fdb39e36b44ff82650dd71496ec9481dfc43a429ff0a90e)

BibTeX

@misc{dca301e009dcda,
  title = {Prospective Evaluation of the Cardiovascular Effects of BRAF and MEK Inhibitors in Patients With Melanoma — Europe PMC PMID:41065626},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41065626},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a301e009dcda; sha256 b42017937d178c703fdb39e36b44ff82650dd71496ec9481dfc43a429ff0a90e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41065626. Agents can read the archived copy with the MCP tool read_document.